RenovoRx Inc (RNXT) Stock Analysis

RenovoRx Inc (RNXT) is a publicly traded company in the HEALTHCARE sector. It trades at $0.91, carries a market capitalization of $41.01M. This page summarizes the public market data, fundamentals, and frequently asked questions for RNXT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.91
• Market Cap: $41.01M
• EPS: $-0.33
• 52-Week High: $1.45
• 52-Week Low: $0.70

Market Sentiment

RenovoRx Inc currently has a Bullish sentiment score of 0.34.

About RenovoRx Inc

RenovoRx, Inc. is a clinical-stage biopharmaceutical company based in Los Altos, California, dedicated to innovating targeted therapies for solid tumors. The company's lead product candidates utilize proprietary delivery systems to maximize the local concentration of therapeutic agents while minimizing systemic exposure, addressing significant unmet needs in oncology. With a robust pipeline and commitment to improving patient outcomes through advanced therapeutic solutions, RenovoRx is positi...

GNG Research Analysis

GNG Research scores RenovoRx Inc (RNXT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for RNXT.

Frequently Asked Questions

Does RNXT pay dividends?

RenovoRx Inc (RNXT) does not currently pay a regular dividend.

What is RNXT's market cap?

RenovoRx Inc (RNXT) has a market capitalization of $41.01M with a current stock price of $0.91.